Congress has approved legislation that ensures long-term funding for the World Trade Center Health Program, preventing a projected multibillion-dollar shortfall that threatened its future. The updated measure revises the program’s financing structure to keep pace with rising medical costs and growing enrollment.
Lawmakers Highlight Commitment to 9/11 Survivors and Responders
Sen. Kirsten Gillibrand, D-N.Y., called the legislation a major step in honoring the nation’s commitment to those affected by toxic exposure following the Sept. 11 attacks. She emphasized that the funding will sustain medical care and monitoring for survivors and first responders through 2040.
Since its creation in 2011, the program has helped more than 150,000 people receive treatment and health monitoring related to 9/11 exposure.
Stability for Patients Facing Long-Term Illness
Supporters say the updated funding structure will provide consistent support for individuals suffering from cancers, respiratory illnesses, and other chronic conditions linked to toxic dust and debris from the attacks in New York, Pennsylvania, and Washington, D.C. Advocates stress that stable funding is critical as many illnesses can take years or decades to develop.
Enrollment in the program has continued to grow as more patients require complex and long-term medical care.
Advocates Note Ongoing Challenges
While the funding marks a significant milestone, advocates warn that the program still faces operational challenges. Staffing shortages, delays in certifying new conditions, and administrative backlogs continue to slow treatment for some patients.
The program is part of the James Zadroga 9/11 Health and Compensation Act, named after a New York City police officer whose death was linked to toxic exposure from the World Trade Center disaster. Supporters say continued improvements will be necessary to ensure the program fully meets the needs of responders and survivors.
For the latest on this story, stay tuned to Que Onda Magazine.